BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2567980)

  • 21. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review.
    Minamoto T; Mai M; Ronai Z
    Cancer Detect Prev; 2000; 24(1):1-12. PubMed ID: 10757118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver.
    Schimanski CC; Linnemann U; Berger MR
    Cancer Res; 1999 Oct; 59(20):5169-75. PubMed ID: 10537293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The balanced induction of K-ras codon 12 and 13 mutations in mucosa differs from their ratio in neoplastic tissues.
    Kraus MC; Seelig MH; Linnemann U; Berger MR
    Int J Oncol; 2006 Oct; 29(4):957-64. PubMed ID: 16964391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sensitive detection of K-ras oncogene codon 12 mutations by nested PCR using mismatched primers and selective digestion of non-mutated PCR fragments with restriction enzyme].
    Fukayama N; Sugano K; Kyogoku A; Nose H; Kondou H; Ohkura H
    Rinsho Byori; 1993 Sep; 41(9):1017-23. PubMed ID: 8254964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid, nonradioactive detection of mutations in the human genome by allele-specific amplification.
    Okayama H; Curiel DT; Brantly ML; Holmes MD; Crystal RG
    J Lab Clin Med; 1989 Aug; 114(2):105-13. PubMed ID: 2787825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular genetics of malignant insulinoma.
    Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
    Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A rapid and simple procedure for the routine detection of ras point mutations in formalin-fixed, paraffin-embedded tissues.
    Slebos RJ; Boerrigter L; Evers SG; Wisman P; Mooi WJ; Rodenhuis S
    Diagn Mol Pathol; 1992 Jun; 1(2):136-41. PubMed ID: 1342959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative detection of mutant alleles of the K-ras gene with minor groove binder-conjugated fluorogenic DNA probes.
    Itabashi T; Maesawa C; Uchiyama M; Higuchi T; Masuda T
    Int J Oncol; 2004 Mar; 24(3):687-96. PubMed ID: 14767554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of point mutations at codon 12 of KI-ras in ophthalmic pterygia.
    Detorakis ET; Zafiropoulos A; Arvanitis DA; Spandidos DA
    Eye (Lond); 2005 Feb; 19(2):210-4. PubMed ID: 15232598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A highly sensitive assay for mutant ras genes and its application to the study of presentation and relapse genotypes in acute leukemia.
    Jacobson DR; Mills NE
    Oncogene; 1994 Feb; 9(2):553-63. PubMed ID: 8290266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of K-ras mutations in DNAs isolated from feces of patients with colorectal tumors by mutant-allele-specific amplification (MASA).
    Hasegawa Y; Takeda S; Ichii S; Koizumi K; Maruyama M; Fujii A; Ohta H; Nakajima T; Okuda M; Baba S
    Oncogene; 1995 Apr; 10(7):1441-5. PubMed ID: 7731696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A modified mutagenic PCR-RFLP method for K-ras codon 12 and 13 mutations detection in NSCLC patients.
    Hatzaki A; Razi E; Anagnostopoulou K; Iliadis K; Kodaxis A; Papaioannou D; Labropoulos S; Vasilaki M; Kosmidis P; Saetta A; Mihalatos M; Nasioulas G
    Mol Cell Probes; 2001 Oct; 15(5):243-7. PubMed ID: 11735295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of hotspot mutations and polymorphisms using an enhanced PCR-RFLP approach.
    Liu WH; Kaur M; Makrigiorgos GM
    Hum Mutat; 2003 May; 21(5):535-41. PubMed ID: 12673796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of K-ras codon 12 mutations in human feces and ages of patients with colorectal cancer (CRC).
    Chien CC; Chen SH; Liu CC; Lee CL; Yang RN; Yang SH; Huang CJ
    Transl Res; 2007 Feb; 149(2):96-102. PubMed ID: 17240321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ha-ras oncogene (codon 12) mutation in thyroid carcinogenesis: analysis of 60 benign and malignant thyroid tumors.
    Bouras M; Parvaz P; Berger N; Paulin C; Revol A
    Ann Biol Clin (Paris); 1995; 53(10-11):549-55. PubMed ID: 8787281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single nucleotide polymorphism detection by polymerase chain reaction-restriction fragment length polymorphism.
    Ota M; Fukushima H; Kulski JK; Inoko H
    Nat Protoc; 2007; 2(11):2857-64. PubMed ID: 18007620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated ras alleles in human carcinoma of the prostate are rare.
    Gumerlock PH; Poonamallee UR; Meyers FJ; deVere White RW
    Cancer Res; 1991 Mar; 51(6):1632-7. PubMed ID: 1998954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative enriched PCR (QEPCR), a highly sensitive method for detection of K-ras oncogene mutation.
    Ronai Z; Minamoto T
    Hum Mutat; 1997; 10(4):322-5. PubMed ID: 9338587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. K-ras oncogene mutations in neoplasias of kidney transplanted patients: preliminary results with a new technique.
    Skalkeas GD; Spandidos DA; Kostakis A; Balafouta-Tseleni S; Choremi E; Iliopoulos D; Haliassos A
    Anticancer Res; 1991; 11(6):2091-3. PubMed ID: 1685646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activated H-ras oncogenes in human kidney tumors.
    Fujita J; Kraus MH; Onoue H; Srivastava SK; Ebi Y; Kitamura Y; Rhim JS
    Cancer Res; 1988 Sep; 48(18):5251-5. PubMed ID: 2457438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.